ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression
Research Project:
ReDREAM (Resistant Depression Response to Esketamine Assessing Metabolomics) Project: Untargeted metabolomics to identify biomarkers of treatment response to intranasal esketamine in individuals with Treatment-Resistant Depression
Principal Investigator:
UMBERTO ALBERT
Project Start Date:
09/27/2023
Project End Date:
10/20/2025
Funders:
MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
Acronym:
ReDREAM
Last update: 12-04-2023 - 20:30
Elenchi di link alle pagine piu' importanti-piu' visitate della Ricerca
Spazio pensati per fornire quelle informazioni periodiche di interesse relative alla Ricerca ("aperte iscrizioni ai Dottorati", …).
